Key result
Warfarin use was associated with blue toe syndrome caused by cholesterol crystal embolization in an elderly man with multiple cardiovascular diseases.
This case highlights the potential for warfarin use to be associated with cholesterol crystal embolisation leading to blue toe syndrome.
Answers are grounded in this paper and cite their sources.
Raises awareness for warfarin-related purple toe syndrome in elderly anticoagulated patients; leaves open need for systematic incidence data.
A man in his early 90s presented with purple discolouration and pain in his toes of uncertain onset. He had multiple, cardiovascular diseases for which he was receiving atorvastatin, low-dose aspirin and warfarin. He had had no invasive medical intervention after receiving a percutaneous, coronary
No takes yet. Share an insight, caveat, or question.
Kano et al. (2023) studied this question. Warfarin use was associated with blue toe syndrome caused by cholesterol crystal embolization in an elderly man with multiple cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: